Submit Your Article CMED MEACR meeting
Home Print this page Email this page Users Online: 430
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2019  |  Volume : 8  |  Issue : 6  |  Page : 254-256

Primary neuroendocrine tumor of breast: Diagnosing and treating a rare case

1 Department of Radiation Oncology, GMCH, Chandigarh, India
2 Department of Pathology, GMCH, Chandigarh, India

Correspondence Address:
Poorva Vias
Department of Radiation Oncology, GMCH, Sector 32, Chandigarh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ccij.ccij_79_19

Rights and Permissions

Neuroendocrine carcinoma breast is a distinct entity. Although clinical features and morphology cannot distinguish it from invasive carcinomas, immunochemistry plays an important role in it. Due to its rarity and lack of clinical data, treatment is followed on the lines of invasive breast carcinoma. Some studies have suggested the use of cisplatin and etoposide for its treatment, but none of them is standard. The prognosis is poor compared to invasive breast cancer.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded3    
    Comments [Add]    
    Cited by others 1    

Recommend this journal